Literature DB >> 32392592

[68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging.

Barbara Kreppel1, Florian C Gärtner1, Milka Marinova2, Ulrike Attenberger2, Michael Meisenheimer1, Marieta Toma3, Glen Kristiansen3, Georg Feldmann4, Euy Sung Moon5, Frank Roesch5, Pieter Van Der Veken6, Markus Essler1.   

Abstract

Entities:  

Year:  2020        PMID： 32392592     DOI： 10.1055/a-1164-5667

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN： 0029-5566            Impact factor:   1.379


× No keyword cloud information.
  9 in total

1.  Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time.

Authors:  Euy Sung Moon; Sanjana Ballal; Madhav Prasad Yadav; Chandrasekhar Bal; Yentl Van Rymenant; Sarah Stephan; An Bracke; Pieter Van der Veken; Ingrid De Meester; Frank Roesch
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-12-15

2.  Increased [68 Ga]Ga-FAPI uptake in focal nodular hyperplasia in a patient with sigmoid colon cancer.

Authors:  Qihang Shang; Li Fu; Yizhen Pang; Tinghua Meng; Xiurong Wu; Long Sun; Haojun Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-08-17       Impact factor: 9.236

Review 3.  FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century.

Authors:  Rong Huang; Yu Pu; Shun Huang; Conghui Yang; Fake Yang; Yongzhu Pu; Jindan Li; Long Chen; Yunchao Huang
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

4.  Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators.

Authors:  Euy Sung Moon; Filipe Elvas; Gwendolyn Vliegen; Stef De Lombaerde; Christel Vangestel; Sven De Bruycker; An Bracke; Elisabeth Eppard; Lukas Greifenstein; Benedikt Klasen; Vasko Kramer; Steven Staelens; Ingrid De Meester; Pieter Van der Veken; Frank Rösch
Journal:  EJNMMI Radiopharm Chem       Date:  2020-07-29

Review 5.  AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications.

Authors:  Cyril Fersing; Nicolas Masurier; Léa Rubira; Emmanuel Deshayes; Vincent Lisowski
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-16

6.  From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [68Ga]Ga-DATA5m.SA.FAPi.

Authors:  Lukas Greifenstein; Carsten S Kramer; Euy Sung Moon; Frank Rösch; Andre Klega; Christian Landvogt; Corinna Müller; Richard P Baum
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-14

7.  In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA5.SA.FAPi and DOTA.SA.FAPi.

Authors:  Euy Sung Moon; Yentl Van Rymenant; Sandeep Battan; Joni De Loose; An Bracke; Pieter Van der Veken; Ingrid De Meester; Frank Rösch
Journal:  Molecules       Date:  2021-06-08       Impact factor: 4.411

8.  First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2.

Authors:  Sanjana Ballal; Madhav Prasad Yadav; Euy Sung Moon; Vasko S Kramer; Frank Roesch; Samta Kumari; Chandrasekhar Bal
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-24

Review 9.  FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors.

Authors:  Tianshuo Yang; Long Ma; Haodong Hou; Feng Gao; Weijing Tao
Journal:  Front Oncol       Date:  2022-01-04       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.